Celltech sells Armstrong to Andrx

Completing its divestment program, Celltech (LSE:CCH; CLL) agreed to sell its Armstrong contract manufacturing business (Boston, Mass.) to ADRX for $18 million. Armstrong specializes in contract manuf...